ImmunoPrecise Antibodies Limited focues on discovering therapeutic antibodies. It aims for species-agnostic advancements such as B cell Select single-cell interrogation technology, DeepDisplay custom phage libraries, and Abthena bispecific program. The company has research collaboration agreements with Pierre Fabre S.A and Elektrofi Inc. ImmunoPrecise Antibodies was incorporated in 1983 and is headquartered in Victoria, British Columbia, Canada.
What is Immunoprecise Antibodies's quote symbol?
What is the 52 week high and low for Immunoprecise Antibodies (NASDAQ: IPA)?
How much is Immunoprecise Antibodies stock worth today?
How much is Immunoprecise Antibodies's stock price per share?
What is Immunoprecise Antibodies's Market Cap?